Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Alessandro STICCHI"'
Autor:
Stefano Benenati, Francesco Gallo, Won-keun Kim, Arif A. Khokhar, Tobias Zeus, Stefan Toggweiler, Roberto Galea, Federico De Marco, Antonio Mangieri, Damiano Regazzoli, Bernhard Reimers, Luis Nombela-Franco, Marco Barbanti, Ander Regueiro, Tommaso Piva, Josep Rodes-Cabau, Italo Porto, Antonio Colombo, Francesco Giannini, Alessandro Sticchi
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 11, Iss 1, p 33 (2024)
Background: Current European guidelines support transcatheter aortic valve implantation (TAVI) in intermediate-to-low-risk patients ≥75 years-old, but its prognostic relevance is unknown. Methods: Intermediate-to-low-risk (The Society of Thoracic S
Externí odkaz:
https://doaj.org/article/abdaf001cdc7407a99fbe7f339debdae
Autor:
Arif A. Khokhar, Francesco Ponticelli, Adriana Zlahoda-Huzior, Kailash Chandra, Rossella Ruggiero, Marco Toselli, Francesco Gallo, Alberto Cereda, Alessandro Sticchi, Alessandra Laricchia, Damiano Regazzoli, Antonio Mangieri, Bernhard Reimers, Simone Biscaglia, Carlo Tumscitz, Gianluca Campo, Ghada W. Mikhail, Won-Keun Kim, Antonio Colombo, Dariusz Dudek, Francesco Giannini
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundCoronary access after transcatheter aortic valve implantation (TAVI) with supra-annular self-expandable valves may be challenging or un-feasible. There is little data concerning coronary access following transcatheter aortic valve-in-valve
Externí odkaz:
https://doaj.org/article/1fb6a91cbc7e43b6a2e5d938a68a5986
Autor:
Antonio Mangieri, Alessandro Sticchi, Aisha Gohar, Damiano Regazzoli, Fabio Fazzari, Daniela Pini, Marta Pellegrino, Beniamino Pagliaro, Ferdinando Loiacono, Mauro Chiarito, Bernhard Reimers, Fabien Praz, Azeem Latib, Antonio Colombo
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 7, p 220 (2022)
Tricuspid regurgitation (TR) negatively affects patient outcomes. Surgical tricuspid valve repair/replacement carries a high operative risk and is not a viable option for many high-risk patients. Percutaneous approaches provide an attractive alternat
Externí odkaz:
https://doaj.org/article/88a8dda88d384b6d826d13a72a51f760
Autor:
Stefano Benenati, Francesco Gallo, Won-keun Kim, Arif A Khokhar, Tobias Zeus, Stefan Toggweiler, Roberto Galea, Federico De Marco, Antonio Mangieri, Damiano Regazzoli, Bernhard Reimers, Luis Nombela-Franco, Marco Barbanti, Ander Regueiro, Tommaso Piva, Josep Rodes-Cabau, Italo Porto, Antonio Colombo, Francesco Giannini, Alessandro Sticchi
Background: Current European guidelines support transcatheter aortic valve implantation (TA-VI) in intermediate to low-risk patients ≥75 years-old but its prognostic relevance is unknown. Methods: Intermediate-to-low-risk (Society of Thoracic Surge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0bf0531a24ab01c90599d9c01e7ee8f
https://doi.org/10.20944/preprints202305.2019.v1
https://doi.org/10.20944/preprints202305.2019.v1
Autor:
Alessandra Laricchia, Alberto Cereda, Stefano Lucreziotti, Alessandro Sticchi, Damiano Regazzoli, Bernhard Reimers, Antonio Colombo, Azeem Latib, Antonio Mangieri
Publikováno v:
Expert Review of Cardiovascular Therapy. 20:497-501
Autor:
Fabio Mangiacapra, Raffaele Rinaldi, Iginio Colaiori, Alessandro Sticchi, Michele Mattia Viscusi, Luca Paolucci, Massimo Russo, Annunziata Nusca, Rosetta Melfi, Elisabetta Ricottini, Paolo Gallo, Gian Paolo Ussia, Francesco Grigioni
Publikováno v:
Heart and Vessels. 37:1471-1477
Percutaneous coronary intervention (PCI) is frequently complicated by type 4a myocardial infarction (MI), which is associated with an increased risk of mortality. We assessed the usefulness of the angiography-derived hemodynamic index (ADDED), which
Autor:
Mauro Gitto, Fabio Fazzari, Guido Del Monaco, Maria Lo Monaco, Costanza Lisi, Damiano Regazzoli, Antonio Frontera, Bernhard Reimers, Lorenzo Monti, Marco Francone, Antonio Mangieri, Antonio Colombo, Alessandro Sticchi
Publikováno v:
European Heart Journal Supplements. 24
Introduction Originally considered as the “forgotten valve disease”, tricuspid regurgitation (TR) has recently been shown to correlate with consistent morbidity and mortality, suggesting the need for a deeper understanding of its natural course.
Autor:
Mauro Chiarito, Angelo Oliva, Laura Novelli, Riccardo Terzi, Matteo Sturla, Emir Lacevic, Anna Giulia Carnabuci, Damiano Regazzoli, Antonio Mangieri, Alessandro Sticchi, Giuseppe Ferrante, Gabriele Gasparini, Paolo Pagnotta, Antonio Colombo, Roxana Mehran, Lucia Torracca, Gianluigi Condorelli, Bernhard Reimers, Giulio G Stefanini
Publikováno v:
European Heart Journal Supplements. 24
Background Recent evidence has rendered percutaneous coronary intervention (PCI) a valuable alternative to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). Nevertheless, the optimal management and pat
Autor:
Alessandro Sticchi, Mauro Gitto, Matteo Pagnesi, Sara Baggio, Andrea Scotti, Marco Barbanti, Giuliano Costa, Marianna Adamo, Federico Di Marco, Matteo Casenghi, Mattia Lunardi, Damiano Regazzoli, Bernhard Reimers, Diego Maffeo, Andrea Buono, Matteo Saccocci, Francesco Giannini, Luca Di Ienno, Giuseppe Lanzillo, Marco Ferlini, Alfonso Ielasi, Azeem Latib, Antonio Mangieri, Antonio Colombo
Publikováno v:
European Heart Journal Supplements. 24
Introduction While randomized controlled trials have widely shown superiority or non-inferiority of transcatheter aortic valve replacement (TAVR) across the whole spectrum of surgical risks, 2021 ESC guidelines on valvular heart disease provide a cla
Autor:
Riccardo Terzi, Mauro Chiarito, Angelo Oliva, Alessandra Iaccarino, Laura Novelli, Anna Giuli Carnabuci, Damiano Regazzoli, Antonio Mangieri, Alessandro Sticchi, Giuseppe Ferrante, Matteo Sturla, Gabriele Gasparini, Paolo Pagnotta, Antonio Colombo, Gianluigi Condorelli, Alessandro Barbone, Lucia Torracca, Bernhard Reimers, Roxana Mehran, Giulio G Stefanini
Publikováno v:
European Heart Journal Supplements. 24
Background Recent evidence has rendered percutaneous coronary intervention (PCI) a valuable alternative to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). Nevertheless, the optimal management and pat